Results 161 to 170 of about 37,311 (268)

Probiotic supplementation during pregnancy for vaginal microbiota improvement and pathogen clearance: A systematic review and meta‐analysis

Acta Obstetricia et Gynecologica Scandinavica, Volume 105, Issue 6, Page 999-1016, June 2026.
Probiotic supplementation during pregnancy shows a modest, non‐robust increase in Group B Streptococcus decolonization, with no consistent benefit for bacterial vaginosis or vulvovaginal candidiasis. Probiotics may serve as a non‐antibiotic adjunct, but standardized regimens and ecological diagnostic frameworks are required.
Zimo Liu, Roujie Huang, Tianshu Sun, Lan Zhu   +3 more
wiley   +1 more source

Prevalence of Oral Fungal Infections Among Hemodialysis Patients and Their Association With Clinical and Demographic Factors: A Retrospective Study. [PDF]

Cureus
Al Momani AM, Al Hammad L, Al Majali N, Al Zgoul B, Hamed A, Khuluqi A.   +5 more
europepmc   +1 more source

Parkinson's Disease and Salivary Issues: A Survey

Gerodontology, Volume 43, Issue 2, Page 234-244, June 2026.
ABSTRACT Background Salivary dysfunction, including xerostomia and drooling, is common in Parkinson's disease and further impairs oral health and quality of life, which are already compromised in this population. Their effective management demands deeper insight into the complexity of salivary dysfunction.
Beau D. M. van Dijk, Merel C. Verhoeff, Niels van der Aa, Frank Lobbezoo   +3 more
wiley   +1 more source

The Role of Herbal Medicine in the Management of Oral Conditions: A Comprehensive Review. [PDF]

J Dent (Shiraz)
Kolahi M, Sobootkar M, Hamidzade S, Ghods K.   +3 more
europepmc   +1 more source

Efficacy and Safety of Oral Icotrokinra in Moderate‐to‐Severe Plaque Psoriasis: A Systematic Review, Meta‐Analysis, and Trial Sequential Analysis

International Journal of Dermatology, Volume 65, Issue 6, Page 1144-1154, June 2026.
Meta‐analysis of randomized controlled trials demonstrates that oral icotrokinra significantly improves PASI responses in patients with moderate‐to‐severe plaque psoriasis, with early clinical benefit and a placebo‐comparable safety profile, supported by trial sequential analysis confirming robust and sufficient evidence.
Alhasan Altayf, Munder Lateiresh, Lutfiyah Marwan, Mohamed Yaseen Alfeetouri, Yassine Zouaoui, Muhammed Elhadi   +5 more
wiley   +1 more source

Atypical cutaneous candidiasis mimicking tinea corporis in an otherwise healthy young man: A case report. [PDF]

Med Mycol Case Rep
Liu S, Song Y, Wang A.
europepmc   +1 more source

Impact of Electronic Cigarette Use on the Oral Microbiota: A Systematic Review

Journal of Clinical Periodontology, Volume 53, Issue 6, Page 956-985, June 2026.
ABSTRACT Aim To examine whether the oral microbiota of e‐cigarette users differs from that of never smokers and current smokers. Materials and Methods PubMed, Scopus and Web of Science were searched on 27 August 2025. Human studies using molecular methods to compare oral microbiota in saliva, subgingival plaque and oral mucosal swabs among e‐cigarette ...
Giusy Rita Maria La Rosa, Lakshman Perera Samaranayake, Egija Zaura, Ang Sun, Virginia Fuochi, Pio Maria Furneri, Jan Kowalski, Karol Myszel, Iain Chapple, Riccardo Polosa   +9 more
wiley   +1 more source

The effectiveness of Annona muricata for improving induced oral candidiasis in gamma-irradiated rats. [PDF]

BMC Complement Med Ther
Bakr MA, Elkady NA, Rasmy AH.
europepmc   +1 more source

Oral health: Asthma and oral candidiasis [PDF]

British Dental Journal, 2017
J S, Chandan, R S, Randhawa, T, Thomas
openaire   +2 more sources

Bimekizumab efficacy and safety in Chinese patients with psoriasis in the BE SHINING Phase 3 study

Journal of the European Academy of Dermatology and Venereology, Volume 40, Issue 6, Page 1019-1029, June 2026.
In Chinese patients with moderate to severe plaque psoriasis, bimekizumab treatment was well tolerated and led to significantly higher clinical response rates versus placebo, including complete skin clearance. These findings were consistent with global studies and suggest that bimekizumab is an effective treatment option for Chinese people living with ...
Lin Cai, Xiao‐Yong Man, Jinyan Wang, Aihua Wei, Ying Chen, Delphine Deherder, Jun Gao, Bengt Hoepken, Weiwei Sun, Tingting Lei, Jianzhong Zhang, the BE SHINING Study Group   +11 more
wiley   +1 more source